ATE447586T1 - Fprl1-liganden und deren verwendung - Google Patents

Fprl1-liganden und deren verwendung

Info

Publication number
ATE447586T1
ATE447586T1 AT03810620T AT03810620T ATE447586T1 AT E447586 T1 ATE447586 T1 AT E447586T1 AT 03810620 T AT03810620 T AT 03810620T AT 03810620 T AT03810620 T AT 03810620T AT E447586 T1 ATE447586 T1 AT E447586T1
Authority
AT
Austria
Prior art keywords
fprl1
seq
amino acid
acid sequence
ligands
Prior art date
Application number
AT03810620T
Other languages
English (en)
Inventor
Shuji Hinuma
Makoto Kobayashi
Yugo Habata
Masataka Harada
Shoichi Okubo
Hiromi Yoshida
Kazunori Nishi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE447586T1 publication Critical patent/ATE447586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03810620T 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung ATE447586T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002324189 2002-11-07
JP2002367119 2002-12-18
JP2003059073 2003-03-05
JP2003191359 2003-07-03
PCT/JP2003/014138 WO2004041850A1 (ja) 2002-11-07 2003-11-06 新規なｆｐｒｌ１リガンドおよびその用途

Publications (1)

Publication Number Publication Date
ATE447586T1 true ATE447586T1 (de) 2009-11-15

Family

ID=32314929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03810620T ATE447586T1 (de) 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung

Country Status (6)

Country Link
US (1) US7943137B2 (de)
EP (1) EP1559721B1 (de)
AT (1) ATE447586T1 (de)
AU (1) AU2003277575A1 (de)
DE (1) DE60329931D1 (de)
WO (1) WO2004041850A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1448600A4 (de) 2001-09-07 2004-12-22 Bristol Myers Squibb Co Für einen neuen menschlichen g-protein-gekoppelten rezeptor hgprbmy39 codierendes polynukleotid
EP2492278A1 (de) 2006-09-18 2012-08-29 Compugen Ltd. Antikörper gegen einen Agonisten von G-Protein-gekoppelten Rezeptoren und deren Verwendung in Diagnose und Therapie
PT2770989T (pt) 2011-10-26 2018-12-04 Allergan Inc Derivados de amida de aminoácidos substituídos por n-ureia como moduladores de recetor tipo-1 do recetor de péptidos formil (fprl-1)
RU2663911C2 (ru) * 2013-03-06 2018-08-13 Аллерган, Инк. Применение агонистов формилпептидного рецептора 2 для лечения воспалительных заболеваний глаз

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2030000A (en) 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
CA2399032A1 (en) * 2000-02-04 2001-08-09 The Government Of The United States Of America Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection
EP2110436B1 (de) * 2000-03-07 2013-01-30 Japan Tobacco Inc. Polypeptide mit Wirkung zur Stimulation von neutrophilen Granulozyten
US7172876B2 (en) 2002-06-14 2007-02-06 Takeda Pharmaceutical Company Limited Method of screening therapeutic agents for nerve degeneration associated diseases
WO2004008141A1 (ja) 2002-07-15 2004-01-22 Takeda Chemical Industries, Ltd. 新規スクリーニング方法

Also Published As

Publication number Publication date
EP1559721B1 (de) 2009-11-04
EP1559721A1 (de) 2005-08-03
AU2003277575A1 (en) 2004-06-07
EP1559721A4 (de) 2006-03-29
DE60329931D1 (de) 2009-12-17
US20070065819A1 (en) 2007-03-22
WO2004041850A1 (ja) 2004-05-21
US7943137B2 (en) 2011-05-17

Similar Documents

Publication Publication Date Title
DK2308855T3 (da) 2,4-Diaminopyrimidinderivater
DE60332320D1 (de) Neues screening-verfahren
SI1706424T1 (sl) Variante fc regij
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60325493D1 (de) Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
EP1700120A4 (de) Marker für neuromyelitis optica
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
DE60315933D1 (de) Polierzusammensetzung und Polierverfahren unter deren Verwendung
PT1454992E (pt) Ensaio de quinase do linfoma anaplastico, reagentes e composicoes
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
DE60322613D1 (de) Frostschutzproteine aus Basidiomyceten
IL165031A0 (en) Quality assays for antigen presenting cells
ITTO20020117A0 (it) Apparecchiatura per prove tribologiche.
DE60329931D1 (de) Fprl1-liganden und deren verwendung
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
EA200500878A1 (ru) Кальцилитические соединения
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
ATE393238T1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
FR2874483B1 (fr) Procede de gradation automatique d'articles, notamment de vetements
ATE511644T1 (de) Neues screening-verfahren
WO2005100386A3 (en) Canine cold-and menthol-sensitive receptor 1
ATE494550T1 (de) Neues screening-verfahren
WO2003082320A1 (fr) Nouveau procede de criblage

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties